Current State of Breast Cancer Diagnosis, Treatment, and Theranostics

Biomimetic “Nanoplatelets” as a Targeted Drug Delivery Platform for Breast Cancer Theranostics

(2021) Lin Li et al.   ACS Applied Materials & Interfaces

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

99mTC-sestamibi breast imaging: Current status, new ideas and future perspectives

(2020) Nicoletta Urbano et al.   SEMINARS IN CANCER BIOLOGY

New Drug Approved for HER2-positive Metastatic Breast Cancer

(2020) Diane S. Aschenbrenner   AMERICAN JOURNAL OF NURSING

Comparison of 99mTc-MIBI scintigraphy, ultrasound, and mammography for the diagnosis of BI-RADS 4 category lesions

(2020) Hongbiao Liu et al.   BMC CANCER

Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer

(2020) Connie Kang et al.   DRUGS

MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions

(2020) Bhavika K. Patel et al.   Clinical Breast Cancer

Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts

(2020) Zhigang Zhang et al.   EUROPEAN RADIOLOGY

Preliminary study on identification of estrogen receptor-positive breast cancer subtypes based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) texture analysis

(2020) Hui Wang et al.   Gland Surgery

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women

(2020) Hongbiao Liu et al.   BMC MEDICAL IMAGING

Shortwave Infrared-Emitting Theranostics for Breast Cancer Therapy Response Monitoring

(2020) Jay V. Shah et al.   Frontiers in Molecular Biosciences

Investigation of CdTe, GaAs, Se and Si as Sensor Materials for Mammography

(2020) Simon Procz et al.   IEEE TRANSACTIONS ON MEDICAL IMAGING

Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment

(2020) Dongdong Zheng et al.   International Journal of Nanomedicine

Contrast-enhanced MRI for breast cancer screening

(2019) Ritse M. Mann et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses

(2019) Guillermo Prado-Vázquez et al.   Scientific Reports

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

(2019) Aditya Bardia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Proton MR spectroscopy in the breast: Technical innovations and clinical applications

(2019) Reza Fardanesh et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

First-line Pembrolizumab vs. Pembrolizumab plus Chemotherapy vs. Chemotherapy alone in Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis

(2019) Ryul Kim et al.   Clinical Lung Cancer

Biomedical Imaging: Principles, Technologies, Clinical Aspects, Contrast Agents, Limitations and Future Trends in Nanomedicines

(2019) Justine Wallyn et al.   PHARMACEUTICAL RESEARCH

Kontrastmittelfreie Mamma-MRT

(2019) P. A. T. Baltzer et al.   RADIOLOGE

A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction

(2019) Adam Yala et al.   RADIOLOGY

Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer

(2019) Qi Dong et al.   Nanoscale Research Letters

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs

(2019) Maira Huerta-Reyes et al.   Frontiers in Oncology

Efficacy of PI3K inhibitors in advanced breast cancer

(2019) B Verret et al.   ANNALS OF ONCOLOGY

Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group

(2019) Pascal Baltzer et al.   EUROPEAN RADIOLOGY

Recent advances in nanotheranostics for triple negative breast cancer treatment

(2019) Vikram Thakur et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Diffusion-Weighted Magnetic Resonance Imaging of Patients with Breast Cancer Following Neoadjuvant Chemotherapy Provides Early Prediction of Pathological Response – A Prospective Study

(2019) Nara P. Pereira et al.   Scientific Reports

G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer

(2019) Shen Xu et al.   Frontiers in Endocrinology

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

(2019) Shanu Modi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diffusion-weighted MRI for Unenhanced Breast Cancer Screening

(2019) Nita Amornsiripanitch et al.   RADIOLOGY

Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

(2019) Nadia R. Ayat et al.   Frontiers in Oncology

An Injectable Supramolecular Polymer Nanocomposite Hydrogel for Prevention of Breast Cancer Recurrence with Theranostic and Mammoplastic Functions

(2018) Yuanhao Wu et al.   ADVANCED FUNCTIONAL MATERIALS

Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: a Network Meta-Analysis

(2018) Xiao-Hong Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis

(2018) Rui Liu et al.   JOURNAL OF CONTROLLED RELEASE

Correlation between the dynamic contrast-enhanced MRI features and prognostic factors in breast cancer

(2018) Weijing Tao et al.   MEDICINE

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

(2018) Andrew Tutt et al.   NATURE MEDICINE

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials

(2018) Xuan Li et al.   PLoS One

New techniques for sentinel node biopsy in breast cancer

(2018) Massimo Ferrucci et al.   Translational Cancer Research

Recent Advances in the Treatment of Breast Cancer

(2018) Christy W. S. Tong et al.   Frontiers in Oncology

Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle

(2018) Imke H. Bartelink et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Abbreviated MRI of the Breast: Does It Provide Value?

(2018) Doris Leithner et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells

(2018) Martin R. Gill et al.   Nanoscale

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

(2018) Andrea Rocca et al.   Cancer Management and Research

Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment

(2018) Rui Liu et al.   Acta Pharmaceutica Sinica B

Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer

(2017) Xin Li et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Tyrosine Kinase Inhibitors for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Is Personalizing Therapy Within Reach?

(2017) Amy Jo Chien et al.   JOURNAL OF CLINICAL ONCOLOGY

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent advances of highly selective CDK4/6 inhibitors in breast cancer

(2017) Hanxiao Xu et al.   Journal of Hematology & Oncology

HER2-positive breast cancer

(2017) Sibylle Loibl et al.   LANCET

A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer

(2017) Jianliang Shen et al.   NANO LETTERS

Real-time sentinel lymph node biopsy guidance using combined ultrasound, photoacoustic, fluorescence imaging: in vivo proof-of-principle and validation with nodal obstruction

(2017) Jeeun Kang et al.   Scientific Reports

Anisotropy of Solid Breast Lesions in 2D Shear Wave Elastography is an Indicator of Malignancy

(2016) Katrin Skerl et al.   ACADEMIC RADIOLOGY

Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice

(2016) Brian L. Sprague et al.   ANNALS OF INTERNAL MEDICINE

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Albert L. Siu et al.   ANNALS OF INTERNAL MEDICINE

Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer

(2016) Romualdo Barroso-Sousa et al.   Breast Care

AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models

(2016) H. M. Weir et al.   CANCER RESEARCH

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer

(2016) Hirofumi Mukai et al.   CANCER SCIENCE

Quantification of breast stiffness using MR elastography at 3 Tesla with a soft sternal driver: A reproducibility study

(2016) Jeffrey R. Hawley et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Breast-Specific  -Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk

(2016) R. F. Brem et al.   JOURNAL OF NUCLEAR MEDICINE

Breast-Dedicated Radionuclide Imaging Systems

(2016) D. F. C. Hsu et al.   JOURNAL OF NUCLEAR MEDICINE

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

(2016) Ian E Krop et al.   LANCET ONCOLOGY

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2016) Arlene Chan et al.   LANCET ONCOLOGY

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

(2016) Massimo Cristofanilli et al.   LANCET ONCOLOGY

Multiparametric MR Imaging of Breast Cancer

(2016) Habib Rahbar et al.   Magnetic Resonance Imaging Clinics of North America

Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer

(2016) Eun Jung Choi et al.   MEDICINE

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

(2016) Gabriel N. Hortobagyi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Palbociclib and Letrozole in Advanced Breast Cancer

(2016) Richard S. Finn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance:Resident and Fellow Education Feature

(2016) Robert R. Flavell et al.   RADIOGRAPHICS

The Warburg Effect: How Does it Benefit Cancer Cells?

(2016) Maria V. Liberti et al.   TRENDS IN BIOCHEMICAL SCIENCES

Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer

(2016) Byeong-Cheol Ahn   Biomed Research International

Alternative Screening for Women With Dense Breasts: Breast-Specific Gamma Imaging (Molecular Breast Imaging)

(2015) Anna Holbrook et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor

(2015) Kimberly Blackwell et al.   BREAST CANCER RESEARCH AND TREATMENT

Quantitative analysis of vascular heterogeneity in breast lesions using contrast-enhanced 3-D harmonic and subharmonic ultrasound imaging

(2015) Anush Sridharan et al.   IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL

Trastuzumab guided nanotheranostics: A lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy

(2015) Priyambada Parhi et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

(2015) Helena M Earl et al.   LANCET ONCOLOGY

Comparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms

(2015) Zongyi Gong et al.   MEDICAL PHYSICS

Original paper Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting

(2015) Agnieszka Adamczyk et al.   POLISH JOURNAL OF PATHOLOGY

Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications

(2015) Kay M. Pepin et al.   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

Tamoxifen Chemoprevention—End of the Road?

(2015) Steven A. Narod   JAMA Oncology

A Multifunctional Polymeric Nanotheranostic System Delivers Doxorubicin and Imaging Agents across the Blood–Brain Barrier Targeting Brain Metastases of Breast Cancer

(2014) Jason Li et al.   ACS Nano

Breast-Specific Gamma Imaging for the Detection of Breast Cancer in Dense Versus Nondense Breasts

(2014) Lauren R. Rechtman et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Diagnostic assessment by dynamic contrast-enhanced and diffusion-weighted magnetic resonance in differentiation of breast lesions under different imaging protocols

(2014) Hongmin Cai et al.   BMC CANCER

Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer

(2014) Sara Tolaney et al.   BREAST CANCER RESEARCH AND TREATMENT

First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan-Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors

(2014) D. Sarker et al.   CLINICAL CANCER RESEARCH

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

(2014) C. Saura et al.   CLINICAL CANCER RESEARCH

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

(2014) Jordi Rodon et al.   INVESTIGATIONAL NEW DRUGS

Investigating the optimal size of anticancer nanomedicine

(2014) L. Tang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Automated Whole Breast Ultrasound

(2014) Stuart S. Kaplan   RADIOLOGIC CLINICS OF NORTH AMERICA

Auditing a Breast MRI Practice: Performance Measures for Screening and Diagnostic Breast MRI

(2014) Bethany L. Niell et al.   Journal of the American College of Radiology

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

(2014) Parvin F. Peddi et al.   Therapeutic Advances in Medical Oncology

Triple-Negative Breast Cancer and the Need for New Therapeutic Targets

(2013) Olav Engebraaten et al.   AMERICAN JOURNAL OF PATHOLOGY

Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson   ANNALS OF INTERNAL MEDICINE

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

(2013) Jeanne S. Mandelblatt   ANNALS OF INTERNAL MEDICINE

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study

(2013) Takayuki Kadoya et al.   BREAST CANCER RESEARCH AND TREATMENT

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

(2013) G. I. Shapiro et al.   CLINICAL CANCER RESEARCH

Integrated Whole-Body PET/MRI With 18F-FDG, 18F-FDOPA, and 18F-FDA in Paragangliomas in Comparison With PET/CT

(2013) Elise M. Blanchet et al.   CLINICAL NUCLEAR MEDICINE

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer

(2013) Zhongzhen Guan et al.   JOURNAL OF CLINICAL ONCOLOGY

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

(2013) Jack Cuzick et al.   LANCET

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

(2013) Stephen RD Johnston et al.   LANCET ONCOLOGY

Radionuclide Methods and Instrumentation for Breast Cancer Detection and Diagnosis

(2013) Suleman Surti   SEMINARS IN NUCLEAR MEDICINE

EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology

(2013) J. Bamber et al.   ULTRASCHALL IN DER MEDIZIN

The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy

(2012) Andrew R. Burke et al.   BIOMATERIALS

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

(2012) Nancy U. Lin et al.   CANCER

Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(ii) mixed-ligand complexes

(2012) Lifeng Tan et al.   DALTON TRANSACTIONS

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer

(2012) Jonas Bergh et al.   JOURNAL OF CLINICAL ONCOLOGY

Review of MR elastography applications and recent developments

(2012) Kevin J. Glaser et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

18F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: A retrospective cohort study

(2012) Soyoung Jin et al.   JOURNAL OF SURGICAL ONCOLOGY

Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer

(2012) Rita S. Mehta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhancement Patterns and Parameters of Breast Cancers at Contrast-enhanced US: Correlation with Prognostic Factors

(2012) Cai Feng Wan et al.   RADIOLOGY

Interpretation of Positron Emission Mammography and MRI by Experienced Breast Imaging Radiologists: Performance and Observer Reproducibility

(2011) Deepa Narayanan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Heterogeneity in breast cancer

(2011) Kornelia Polyak   JOURNAL OF CLINICAL INVESTIGATION

Principles and Applications of Diffusion-weighted Imaging in Cancer Detection, Staging, and Treatment Follow-up

(2011) Ashkan A. Malayeri et al.   RADIOGRAPHICS

Breast MR with special focus on DW-MRI and DCE-MRI

(2011) G. Petralia et al.   CANCER IMAGING

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Second-look us examination of MR-detected breast lesions

(2010) Rosalind Candelaria et al.   JOURNAL OF CLINICAL ULTRASOUND

Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient

(2010) Paul Baron et al.   NMR IN BIOMEDICINE

Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?

(2009) Gwen M. Grimsby et al.   AMERICAN JOURNAL OF SURGERY

Triple negative breast cancers: Clinical and prognostic implications

(2009) S.J. Dawson et al.   EUROPEAN JOURNAL OF CANCER

A systematic review of FDG-PET in breast cancer

(2009) S. Escalona et al.   MEDICAL ONCOLOGY

A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3T

(2009) Jiani Hu et al.   MEDICAL PHYSICS

Targeting the phosphoinositide 3-kinase pathway in cancer

(2009) Pixu Liu et al.   NATURE REVIEWS DRUG DISCOVERY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†

(2008) Adrian J. Folkes et al.   JOURNAL OF MEDICINAL CHEMISTRY

Correlation between High Resolution Dynamic MR Features and Prognostic Factors in Breast Cancer

(2008) Shin Ho Lee et al.   KOREAN JOURNAL OF RADIOLOGY

DCEMRI of breast lesions: Is kinetic analysis equally effective for both mass and nonmass-like enhancement?

(2008) Sanaz A. Jansen et al.   MEDICAL PHYSICS

Theranostic nanomedicine for cancer

(2008) Baran Sumer et al.   Nanomedicine

Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer

(2008) Lindsay W. Turnbull   NMR IN BIOMEDICINE

Significance of Sentinel Lymph Node Micrometastases in Human Breast Cancer

(2007) Charles E. Cox et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Meta-Analysis of MR Imaging in the Diagnosis of Breast Lesions

(2007) Nicky H. G. M. Peters et al.   RADIOLOGY